Close Menu

NIH funding

The bipartisan bill passed both the House and Senate by large margins and increases the NIH's budget by 5.4 percent over its fiscal 2018 funding level.

UCSD plans to expand the Metabolomics Workbench to include a wide range of clinical trials data including demographics and trial protocols.

The centers will generate genotype and whole-genome sequence data from the samples submitted by participants.

Applicants will be expected to develop the capacity to conduct up to 200,000 genome-wide assays per year and generate high-quality genotyping and genome sequence data.

The six-year, $190 million Somatic Cell Genome Editing program aims to remove barriers that slow the adoption of genome editing for treating patients.

In a wide-ranging discussion, the two leaders touched upon vaccine development, infant mortality, US education, research funding, machine learning, and precision medicine.

Hospital will partner with several other institutions in this effort to support data-driven research into pediatric cancers and structural birth defects.

Biotech and academic leaders met with Trump administration officials to discuss NIH funding, ScienceInsider reports.

The funding will be used to develop new software and data structures to enable researchers to use the GO data for network-based analysis. 

The funding builds on more than $1.7 million already awarded to the firm, which is building a diagnostic for characterizing patients in clinical trials.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.